about
Improving vaccines by incorporating immunological coadjuvants.Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.Challenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models.Perspectives on the future of postmarket vaccine safety surveillance and evaluation.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Methods of ensuring vaccine safety.
@ast
Methods of ensuring vaccine safety.
@en
type
label
Methods of ensuring vaccine safety.
@ast
Methods of ensuring vaccine safety.
@en
prefLabel
Methods of ensuring vaccine safety.
@ast
Methods of ensuring vaccine safety.
@en
P2860
P356
P1476
Methods of ensuring vaccine safety.
@en
P2093
Robert Ball
P2860
P304
P356
10.1586/14760584.1.2.161
P577
2002-08-01T00:00:00Z